Dow INC

Market Movers (8-K)

NYSE
Dow Inc. announced robust second quarter 2026 financial results, driven by significant price increases across all operating segments and effective self-help initiatives.
Better than expected
NYSE
Dow Inc. has filed a Form 8-K to register 5,410,000 shares of common stock for issuance under its 2019 Stock Incentive Plan.
NYSE
Dow Inc. announced its first quarter 2026 results, reporting a 6% year-over-year decrease in net sales to $9.8 billion, primarily due to lower prices and volumes impacted by global conflicts and maintenance, though cash flow from operations significantly improved.
Worse than expected
NYSE
Dow Inc. has announced a leadership transition with Karen S. Carter appointed as the new CEO, succeeding Jim Fitterling who will become Executive Chair, effective July 1, 2026.
NYSE
Dow Inc. and The Dow Chemical Company filed an 8-K to provide a comprehensive description of their registered common stock and various outstanding debt securities for their upcoming 2025 Annual Report.
NYSE
Dow Inc. announced a significant net loss of $1.5 billion in Q4 2025, with net sales down 9% year-over-year, reflecting broad declines across all operating segments.
Worse than expected

Quarterly Earnings (10-Q)

NYSE
Dow Inc. announced a 20% increase in net sales for Q2 2026 compared to the prior year, driven by significant price hikes across all segments and regions, despite a slight dip in volume.
Better than expected
NYSE
Dow Inc. reported a net loss of $533 million for Q1 2026, with net sales down 6% year-over-year, impacted by lower prices and ongoing restructuring efforts.
Worse than expected
NYSE
Dow Inc. reported a significant net loss for the first nine months of 2025 and cut its quarterly dividend by 50% in response to challenging macroeconomic conditions and industry overcapacity.
Worse than expected
Delay expected
Capital raise
NYSE
Dow Inc. reported a substantial net loss in the second quarter of 2025, driven by lower sales, significant restructuring charges, and challenging macroeconomic conditions, leading to a 50% reduction in its quarterly dividend.
Worse than expected
Delay expected
Capital raise
NYSE
Dow Inc. reported a net loss for Q1 2025, impacted by challenging market conditions and macroeconomic uncertainty, leading to strategic actions including cost reductions and project delays.
Worse than expected
Delay expected
NYSE
Dow Inc. and The Dow Chemical Company reported a slight increase in net sales but a decrease in net income for the third quarter of 2024, while also announcing a strategic review of European assets.
Worse than expected

Annual Reports (10-K)

NYSE
Dow Inc. posted a substantial net loss in 2025, driven by declining sales, goodwill impairment, and extensive restructuring efforts in a challenging macroeconomic environment.
Delay expected
Worse than expected
Capital raise
NYSE
Dow Inc.'s FY24 results show a slight sales decrease, but the company is implementing cost reduction measures and focusing on strategic growth areas.
Better than expected
NYSE
Dow Inc. and The Dow Chemical Company released their combined 2023 annual report, highlighting a 22% decrease in net sales to $45 billion, alongside strategic investments in sustainability and growth.
Worse than expected

Insider Trading (Form 4)

NYSE
Dow Inc. Chief Executive Officer Karen S. Carter has reported transactions involving company stock, including the acquisition of restricted stock units and non-qualified stock options.
NYSE
Dow Inc. Chair and CEO James R. Fitterling filed an amendment to correct an erroneously reported transaction in a previous Form 4 filing.
NYSE
Dow Inc. Director Richard K. Davis reported a transaction involving the acquisition of 5,127 shares of common stock, settled from vested restricted stock units upon separation.
NYSE
Dow Inc. reports insider transactions by Director Wesley G. Bush, involving the acquisition of common stock and settlement of phantom stock units.
NYSE
Dow Inc. Director Jacqueline C. Hinman reported transactions involving the acquisition of 5,127 shares of common stock, settled from vested restricted stock units.
NYSE
Dow Inc. Director Debra L. Dial reported transactions involving 5,127 shares of common stock, settled from vested restricted stock units upon separation.

Proxy Statements (Def-14A)

NYSE
Dow Inc. announces its 2026 Annual Meeting of Stockholders, outlining key proposals including director elections, executive compensation, and a stock incentive plan amendment.
NYSE
Dow Inc. announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and a stock incentive plan amendment.
NYSE
Dow Inc. reports a net loss in 2025 amidst challenging macroeconomic conditions, while advancing strategic cost reductions, asset partnerships, and a significant stock incentive plan amendment.
Worse than expected
Delay expected
Capital raise
NYSE
Dow Inc. is soliciting proxies for its 2025 Annual Meeting of Stockholders, encouraging shareholders to vote on the election of directors, executive compensation, and the ratification of the company's independent auditor.
NYSE
Dow Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on April 10, 2025, and provides details on voting procedures and proposals.
NYSE
Dow Inc.'s proxy statement details the agenda for the 2025 Annual Meeting of Stockholders, highlighting director elections, executive compensation, and the ratification of the company's independent auditor.
Worse than expected

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has filed a Schedule 13G reporting beneficial ownership of 7.41% of Dow Inc. common stock.
NYSE
The Vanguard Group filed an amended Schedule 13G for Dow Inc., reporting 0% beneficial ownership following an internal realignment.